PATRICIA OKEKE: Open Payments
NPI 1841906278 · SHARPSBURG, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$966 in 49 payments from 19 companies in 2025. Trend: 2023 $15 · 2024 $466 · 2025 $966
Food & beverage: $966
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $152 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $113 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $108 |
| PFIZER INC. | 4 | $66 |
| Sumitomo Pharma America, Inc. | 3 | $63 |
| Novo Nordisk Inc | 2 | $55 |
| Janssen Pharmaceuticals, Inc | 2 | $48 |
| Lilly USA, LLC | 2 | $44 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $37 |
| SANOFI-AVENTIS U.S. LLC | 2 | $37 |
Products named: JARDIANCE, Kerendia, AIRSUPRA, NURTEC ODT, GEMTESA, Ozempic, SPRAVATO, XIFAXAN.
Industry payments across GA — which companies pay providers there.
